DNA damage response, genetic instability and cancer: From mechanistic insights to personalized treatment

Molecular Oncology

Volumn 5, Issue 4, 2011, Pages 303-307

  Bartek, Jiri ^a,b  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CIGARETTE SMOKE; HISTONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN P53;

ACETYLATION; AGING; ANEUPLOIDY; ANTINEOPLASTIC ACTIVITY; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER CELL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CENTROSOME; CHEMOTHERAPY; CHINA; CHROMATIN STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME CONDENSATION; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; EDITORIAL; ENZYME INHIBITION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; GLIOBLASTOMA; HEALTH CARE QUALITY; HIGH THROUGHPUT SEQUENCING; HUMAN; LIFESTYLE; LOSS OF FUNCTION MUTATION; METASTASIS; MITOSIS; MITOSIS SPINDLE; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NEOPLASM; NIJMEGEN BREAKAGE SYNDROME; ONCOGENE; OVARY CANCER; OXIDATIVE STRESS; PATIENT CARE; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE; RADIOSENSITIVITY; SENESCENCE; SOMATIC MUTATION; SUMOYLATION; TETRAPLOIDY; TUMOR GENE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; UBIQUITINATION; ULTRAVIOLET RADIATION; UNSPECIFIED SIDE EFFECT; XERODERMA PIGMENTOSUM;

EID: 80052166397     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2011.07.006     Document Type: Editorial

References (33)

1. Ashworth A., Lord C.J., Reis-Filho J.S. Genetic interactions in cancer progression and treatment. Cell 2011, 145:30-38.
2. Aylon Y., Oren M. p53: Guardian of ploidy. Mol. Oncol 2011, 5(4):315-323.
3. Bartek J., Bartkova J., Lukus J. DNA damage signalling guarda against activated oncogenes and tumour progression. Oncogene 2007, 26:7773-7779.
4. Bartkova J., Hamerlik P., Stockhausen M.T., Ehrmann J., Hlobilkova A., Laursen H., et al. Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas. Oncogene 2010, 29:5095-5102.
5. Bartkova J., Horejsi Z., Koed K., Krämer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Ørntoft T., Lukas J., Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005, 434:864-870.
6. Bartkova J., Rezaei N., Karakaidos P., Vassiliou L.-V.F., Liontos M., Issaeva N., Koletas E., Niforou K., Zoumpourlis V.C., Takaoka M., Nakagawa H., Tort F., Fugger K., Jonansson F., Sehested M., Andersen C.L., Dyrskjot L., Orntoft T., Lukas J., Kittas C., Helleday T., Halazonetis T.D., Bartek J., Gorgoulis V.G. Oncogene-induced senescence is a integral part of tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
7. Bartkova J., Tommiska J., Oplustilova L., Aaltonen K., Tamminen A., Heikkinen T., Mistrik M., Aittomäki K., Blomqvist C., Heikkilä P., Lukas J., Nevanlinna H., Bartek J. Aberrations of the Mre11-Rad50-Nbs1 DNA damage sensor complex in human breast cancer: Mre11 as a candidate familial cancer-predisposing gene. Mol. Oncol. 2008, 2:296-316.
8. Branzei D., Foiani M. Maintaining genome stability at the replication fork. Nat. Rev. Mol. Cell. Biol. 2010, 11:208-219.
9. Bryant H.E., Schultz N., Thomas H.D., Parker K.M., Flower D., Lopez E., Kyle S., Meuth M., Curtin N.J., Helleday T. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005, 434:913-917.
10. Cimprich K.A., Cortez D. ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell. Biol. 2008, 9:616-627.
11. Dereli-Öz A., Versini G., Halazonetis T.D. Studies of genomic copy number changes in human cancers reveal signatures of DNA replication stress. Mol. Oncol 2011, 5(4):308-314.
12. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre M., Nuciforo P.G., Bensimon A., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444:638-642.
13. Farmer H., McCabe N., Lord C.J., Tutt A.N., Johnson D.A., Richardson T.B., Santarosa M., Dillon K.J., Hickson I., Knights C., et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005, 434:917-921.
14. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 10.1002/ijc.25516.
15. Fong P.C., Boss D.S., Yap T.A., Tutt A., Wu P., Mergui-Roelvink M., Mortimer P., Swaisland H., Lau A., O'Connor M.J., et al. Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 2009, 361:123-134.
16. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., Ditullio R.A., Kastrinakis N.G., Levy B., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005, 434:907-913.
17. Halazonetis T.D., Gorgoulis V.G., Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008, 319:1352-1355.
18. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
19. Harrigan J.A., Belotserkovskaya R., Coates J., Dimitrova D.S., Polo S.E., Bradshaw C.R., Fraser P., Jackson S.P. Replication stress induces 53BP1-containing OPT domains in G1 cells. J. Cell. Biol. 2011, 193:97-108.
20. Helleday T. The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings. Mol. Oncol 2011, 5(4):387-393.
21. Jackson S.P., Bartek J. The DNA damage response in human biology and disease. Nature 2009, 461:1071-1078.
22. Jiang H., Reinhardt H.C., Bartkova J., Tommiska J., Blomqvist C., Nevanlinna H., Bartek J., Yaffe M.B., Hemann M.T. The combined status of ATM and p53 link tumor development with therapeutic response. Genes Dev. 2009, 23:1895-1909.
23. Kastan M.B., Bartek J. Cell cycle checkpoints and cancer. Nature 2004, 432:316-323.
24. Krämer A., Maier B., Bartek J. Centrosome clustering and chromosomal (in)stability: A matter of life and death. Mol. Oncol 2011, 5(4):324-335.
25. Luijsterburg M.S., van Attikum H. Chromatin and the DNA damage response: the cancer connection. Mol. Oncol 2011, 5(4):349-367.
26. Lukas C., Sacic V., Bekker-Jensen S., Doil C., Neumann B., Pedersen R.S., Grøfte M., Chan K.L., Hickson I.D., Bartek J., Lukas J. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat. Cell. Biol. 2011, 13:243-253.
27. Luo J., Solimini N.L., Elledge S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009, 136:823-837.
28. Malette F.A., Ferbeyre G. The DNA damage signaling pathway connects oncogenis stress to cellular senescence. Cell Cycle 2007, 6:1831-1836.
29. Mannino M., Chalmers A.J. Radioresistance of glioma stem cells: intrinsic characteristic or property of the 'microenvironment-stem cell unit'?. Mol. Oncol 2011, 5(4):374-386.
30. Negrini S., Gorgoulis V.G., Halazonetis T.D. Genomic instability - an evolving hallmark of cancer. Nat. Rev. Mol. Cell. Biol. 2010, 11:220-228.
31. Rashi-Elkeles S., Elkon R., Shavit S., Lerenthal Y., Linhart C., Kupershtein A., Amariglio N., Rechavi G., Shamir R., Shiloh Y. Transcriptional modulation induced by ionizing radiation: p53 remains a central player. Mol. Oncol 2011, 5(4):336-348.
32. Toledo L.I., Murga M., Fernandez-Capetillo O. Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs. Mol. Oncol 2011, 5(4):368-373.
33. Walsh T., Lee M.K., Casadei S., Thornton A.M., Stray S.M., Pennil C., Nord A.S., Mandell J.B., Swisher E.M., King M.C. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc. Natl. Acad. Sci. USA 2010, 107:12629-12633.